Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AstraZeneca
Pharma
AZ’s reported $10B offer for Rhythm fuels talks of a bidding war
Analysts at Jefferies, Leerink and William Blair suggest a bidding war could be brewing and that Rhythm is unlikely to settle for AZ’s current pitch.
Angus Liu
Nov 5, 2026 9:36am
AstraZeneca launches $1.5B savings plan to fuel pipeline growth
Oct 30, 2026 10:46am
Enhertu successor, ESMO, Gilead—Fierce Pharma Asia
Oct 30, 2026 8:45am
AZ enlists former teen TV star for biomarker testing push
Oct 29, 2026 2:41pm
ESMO: AZ, Hutchmed’s Orpathys combo shows post-Tagrisso power
Oct 25, 2026 11:30am
Akeso CEO looks for more ivonescimab combos after AZ deal
Oct 25, 2026 11:30am
